Search research articles
Contact Us
Filters
Showing results (491-500 of 552) with videos related to
Page
of 56
Sort By:
Journal of Lipid Research
|
January 23, 2020
The citrus flavonoid nobiletin confers protection from metabolic dysregulation in high-fat-fed mice independent of AMPK
Nadya M Morrow, Amy C Burke, Joshua P Samsoondar, et al.
BMC Psychiatry
|
June 26, 2023
Design of a real-world, prospective, longitudinal, observational study to compare vortioxetine with other standard of care antidepressant treatments in patients with major depressive disorder: a PatientsLikeMe survey
Subhara Raveendran, Deepshikha Singh, Mary C Burke, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 28, 2009
Evaluation of intervention to prevent hypomagnesemia in cervical cancer patients receiving combination cisplatin and radiation treatment
Rodney J Hunter, Makala B Pace, Kimberly A Burns, et al.
Circulation
|
January 25, 2000
Atypical atrial flutter originating in the right atrial free wall
J G Kall, D S Rubenstein, D E Kopp, et al.
Pacing and Clinical Electrophysiology : PACE
|
December 13, 2016
The Design of the Understanding Outcomes with the S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED)
Michael R Gold, Reinoud Knops, Martin C Burke, et al.
JACC. Clinical Electrophysiology
|
May 16, 2018
Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator
Fleur V Y Tjong, Tom F Brouwer, Brendan Koop, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
August 18, 2014
Impact of implantable transvenous device lead location on severity of tricuspid regurgitation
Karima Addetia, Francesco Maffessanti, Anuj Mediratta, et al.
JACC. Clinical Electrophysiology
|
May 16, 2018
Outcomes in Patients With Congenital Heart Disease Receiving the Subcutaneous Implantable-Cardioverter Defibrillator: Results From a Pooled Analysis From the IDE Study and the EFFORTLESS S-ICD Registry
Benjamin A D'Souza, Andrew E Epstein, Fermin C Garcia, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 26, 2013
Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice
Lazar A Bojic, Amy C Burke, Sanjiv S Chhoker, et al.
Arthroplasty Today
|
September 25, 2023
Racial Differences in Patient Satisfaction With the Hospital Experience Undergoing Primary Unilateral Hip and Knee Arthroplasty: A Retrospective Study
Orett C Burke, J Alex B Gibbons, Huong T Do, et al.
Page
of 56
Search research articles
Search
Showing results (491-500 of 552) with videos related to
Sort By:
Page
of 56
Journal of Lipid Research
|
January 23, 2020
The citrus flavonoid nobiletin confers protection from metabolic dysregulation in high-fat-fed mice independent of AMPK
Nadya M Morrow, Amy C Burke, Joshua P Samsoondar, et al.
BMC Psychiatry
|
June 26, 2023
Design of a real-world, prospective, longitudinal, observational study to compare vortioxetine with other standard of care antidepressant treatments in patients with major depressive disorder: a PatientsLikeMe survey
Subhara Raveendran, Deepshikha Singh, Mary C Burke, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 28, 2009
Evaluation of intervention to prevent hypomagnesemia in cervical cancer patients receiving combination cisplatin and radiation treatment
Rodney J Hunter, Makala B Pace, Kimberly A Burns, et al.
Circulation
|
January 25, 2000
Atypical atrial flutter originating in the right atrial free wall
J G Kall, D S Rubenstein, D E Kopp, et al.
Pacing and Clinical Electrophysiology : PACE
|
December 13, 2016
The Design of the Understanding Outcomes with the S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED)
Michael R Gold, Reinoud Knops, Martin C Burke, et al.
JACC. Clinical Electrophysiology
|
May 16, 2018
Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator
Fleur V Y Tjong, Tom F Brouwer, Brendan Koop, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
August 18, 2014
Impact of implantable transvenous device lead location on severity of tricuspid regurgitation
Karima Addetia, Francesco Maffessanti, Anuj Mediratta, et al.
JACC. Clinical Electrophysiology
|
May 16, 2018
Outcomes in Patients With Congenital Heart Disease Receiving the Subcutaneous Implantable-Cardioverter Defibrillator: Results From a Pooled Analysis From the IDE Study and the EFFORTLESS S-ICD Registry
Benjamin A D'Souza, Andrew E Epstein, Fermin C Garcia, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 26, 2013
Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice
Lazar A Bojic, Amy C Burke, Sanjiv S Chhoker, et al.
Arthroplasty Today
|
September 25, 2023
Racial Differences in Patient Satisfaction With the Hospital Experience Undergoing Primary Unilateral Hip and Knee Arthroplasty: A Retrospective Study
Orett C Burke, J Alex B Gibbons, Huong T Do, et al.
Page
of 56